Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KISHAN AU, Duchesne G, Wang PC, Rwigema JM, et al
    Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000381.
    PubMed     Text format     Abstract available


    February 2017
  2. SHAIKH MP, Alite F, Wu MJ, Solanki AA, et al
    Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis.
    Am J Clin Oncol. 2017 Feb 20. doi: 10.1097/COC.0000000000000358.
    PubMed     Text format     Abstract available


    January 2017
  3. MCLAUGHLIN PW, Liss AL, Nguyen PL, Assimos DG, et al
    ACR Appropriateness Criteria Locally Advanced, High-Risk Prostate Cancer.
    Am J Clin Oncol. 2017 Jan 4. doi: 10.1097/COC.0000000000000354.
    PubMed     Text format     Abstract available


    November 2016
  4. BITTNER N, Merrick G, Taira A, Bennett A, et al
    Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  5. HOFFMAN KE, Skinner H, Pugh TJ, Voong KR, et al
    Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  6. KISHAN AU, Duchesne G, Wang PC, Rwigema JM, et al
    Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  7. HEGDE JV, Collins SP, Fuller DB, King CR, et al
    A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  8. SHAH C, Kotecha R, Stephans K, Tendulkar R, et al
    Radiation Therapy in Prostate Cancer: Defining the Benefit of Hypofractionation.
    Am J Clin Oncol. 2016.
    PubMed     Text format    


  9. ZAORSKY NG, Egleston BL, Horwitz EM, Dicker AP, et al
    The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  10. SHILKRUT M, McLaughlin PW, Merrick GS, Vainshtein JM, et al
    Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy.
    Am J Clin Oncol. 2016;39:181-8.
    PubMed     Text format     Abstract available


  11. VAINSHTEIN JM, Schipper M, Vance S, Feng FY, et al
    Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy.
    Am J Clin Oncol. 2016;39:173-80.
    PubMed     Text format     Abstract available


  12. CREHANGE G, Izaguirre A, Weinberg V, Hsu CC, et al
    Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery.
    Am J Clin Oncol. 2016;39:167-72.
    PubMed     Text format     Abstract available


    March 2016
  13. ZAORSKY NG, Keith SW, Shaikh T, Nguyen PL, et al
    Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  14. KENDAL WS
    Age Bias in Time From Diagnosis Comparisons of Prostate Cancer Treatment.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  15. COLLOCA G, Venturino A, Guarneri D
    Tumor Growth Kinetics Before and After First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: A Prostate-specific Antigen-based Retrospective Analysis.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  16. MORAES FY, Leite ET, Hamstra DA, Feng FY, et al
    Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  17. WHITE EC, Murphy JD, Chang DT, Koong AC, et al
    Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
    Am J Clin Oncol. 2015;38:564-9.
    PubMed     Text format     Abstract available


    October 2015
  18. VARGAS CE, Hartsell WF, Dunn M, Keole SR, et al
    Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  19. YING J, Wang CJ, Yan J, Liauw SL, et al
    Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  20. LAWRENCE YR, Samueli B, Levitin R, Pail O, et al
    Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  21. BITTNER N, Merrick GS, Bennett A, Butler WM, et al
    Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
    Am J Clin Oncol. 2015;38:300-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: